The AJMC® Asthma compendium is a comprehensive resource for clinical news and expert insights for the chronic lung disease.
December 17th 2025
Twice-yearly depemokimab cuts asthma exacerbations in phase 3 trials for patients aged 12 and older with severe eosinophilic asthma.
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
View More
Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage
1.5 Credits / Immunization, Infectious Disease, Pulmonology
View More
Reflecting on the Real-World Use of Biologic Therapy in Asthma Management
1.5 Credits / Immunology, Pulmonology
View More
Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists
1.5 Credits / Pulmonology
View More
Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies
1.5 Credits / Pulmonology, Cardiology, Rare Diseases
View More
Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC
2.0 Credits / Lung Cancer, Oncology, Pulmonology/Respiratory
View More
Payment for Pharmacist Services: 2025 Update
1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law
View More
An American Journal of Managed Care Forum: Bridging Evidence and Access in Advanced Small Cell Lung Cancer
1.5 Credit / Lung Cancer, Oncology, Pulmonology
View More
Report Describes Consequences of Airway Remodeling in Pediatric Nonresponders to Omalizumab
January 28th 2022A recent case report described 3 pediatric patients with severe asthma whose disease was not managed according to care guidelines and who did not respond to the biologic by the time they began therapy.
Read More